Corbus Pharmaceuticals Holdings, Inc. (CRBP)
4.05
-0.08
(-1.94%)
USD |
NASDAQ |
Oct 23, 16:00
4.04
-0.01
(-0.25%)
After-Hours: 20:00
Corbus Pharmaceuticals Holdings Price to Book Value : 0.7396 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 0.7396 |
| October 22, 2026 | 0.7542 |
| October 21, 2026 | 0.7825 |
| October 20, 2026 | 0.8072 |
| October 19, 2026 | 0.8145 |
| October 16, 2026 | 0.8255 |
| October 15, 2026 | 0.7908 |
| October 14, 2026 | 0.8054 |
| October 13, 2026 | 0.8729 |
| October 12, 2026 | 0.9624 |
| October 09, 2026 | 0.9825 |
| October 08, 2026 | 0.9624 |
| October 07, 2026 | 1.003 |
| October 06, 2026 | 1.056 |
| October 05, 2026 | 1.068 |
| October 02, 2026 | 1.120 |
| October 01, 2026 | 1.158 |
| September 30, 2026 | 1.246 |
| September 29, 2026 | 1.211 |
| September 28, 2026 | 1.264 |
| September 25, 2026 | 1.304 |
| September 24, 2026 | 1.360 |
| September 23, 2026 | 1.414 |
| September 22, 2026 | 1.438 |
| September 21, 2026 | 1.397 |
| Date | Value |
|---|---|
| September 18, 2026 | 1.366 |
| September 17, 2026 | 1.326 |
| September 16, 2026 | 1.326 |
| September 15, 2026 | 1.264 |
| September 14, 2026 | 1.476 |
| September 11, 2026 | 1.483 |
| September 10, 2026 | 1.505 |
| September 09, 2026 | 1.618 |
| September 08, 2026 | 1.935 |
| September 04, 2026 | 2.024 |
| September 03, 2026 | 2.093 |
| September 02, 2026 | 2.096 |
| September 01, 2026 | 2.06 |
| August 31, 2026 | 1.992 |
| August 28, 2026 | 1.992 |
| August 27, 2026 | 2.033 |
| August 26, 2026 | 2.064 |
| August 25, 2026 | 2.066 |
| August 24, 2026 | 1.952 |
| August 21, 2026 | 1.896 |
| August 20, 2026 | 1.797 |
| August 19, 2026 | 1.824 |
| August 18, 2026 | 1.841 |
| August 17, 2026 | 1.916 |
| August 14, 2026 | 1.843 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.599 |
| Alnylam Pharmaceuticals, Inc. | 22.13 |
| Anika Therapeutics, Inc. | 2.088 |
| Savara, Inc. | 6.034 |
| Vericel Corp. | 5.881 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0221 |
| Price | 4.05 |
| Earnings Yield | -152.5% |
| Market Cap | 75.62M |
| PEGY Ratio | -0.0221 |